Improving Male Sexual Health, Function & Fertility | Dr. Michael Eisenberg

Huberman opens by surfacing a culturally loaded claim rather than a settled fact: declining sperm quality is frequently bundled with anxieties about environmental decline, behavior, and even intelligence. He lists candidate explanations people assume (environmental change, less exercise, less sunlight) while explicitly flagging uncertainty, then reduces the discussion to two answerable questions: whether sperm quality is actually falling, and what the term means. Eisenberg's brief acknowledgements punctuate the setup without committing to a position. The opening monologue also previews recurring themes of the episode, including the claim that only a very small share of erectile dysfunction stems from hormone dysfunction, with the vast majority vascular or neural in origin, and that penile length appears to be increasing over time while sperm counts appear to be declining.

Eisenberg defines sperm quality operationally through the clinical semen analysis rather than as a single number. The core parameters are ejaculate volume, sperm count, motility (movement), and morphology (shape); rarer, more advanced tests examine DNA fragmentation and newer epigenetic profiles of sperm. He stresses that these are markers for fertility, not fertility itself, because a man cannot be labeled fertile or subfertile without information about his partner. The World Health Organization revisits the literature roughly every decade to set cut points separating normal from subfertile values, and that is the backdrop against which any claimed decline has to be judged.

fertility in itself is a team sport

The historical case for decline rests on a landmark early-1990s paper by Carlsen and a Danish group, which pooled studies reporting semen quality worldwide and reported a temporal decline across the preceding fifty years, with earlier mid-20th-century studies showing higher values and more recent studies lower ones. Eisenberg notes the study was very controversial. Huberman adds a methodological confound: as measurement instruments get finer and add sensitive dimensions such as DNA fragmentation, apparent quality can tier into worse-looking levels even without a real biological change. He then reframes the question around a harder endpoint, asking what fraction of failed pregnancies among couples (assuming egg quality is not the issue) is attributable to deficient sperm, and whether that fraction is rising over time.

Eisenberg argues that infertility is still culturally coded as a female problem for historic reasons, and quantifies the gap with US data: when couples seek fertility care the man is bypassed about a third of the time, even though the male partner contributes to infertility about half the time. Huberman asks for confirmation of that half figure and Eisenberg repeats it without qualification. The point is that a large share of male-factor infertility is never investigated at the outset, which is why he calls for a huge need simply to understand and evaluate the man.

the bar has gone down dramatically

Eisenberg traces the neglect of male fertility research to a technological success story. He calls IVF, and specifically intracytoplasmic sperm injection, one of the greatest marvels of medicine of probably the last quarter-century, since mixing a sperm and egg in a dish can create a life. Unassisted conception probably requires 20 to 40 million moving sperm, but ICSI needs only a single sperm injected into an egg. Because the clinical bar has collapsed to a few dozen sperm for most couples, he argues that a lot of innovation and research on male fertility has probably gone to the wayside: there is little clinical pressure to understand or improve sperm when one cell suffices.

Huberman shifts to testosterone, noting that a decline is often reported and that he can find supporting literature, but questioning whether the magnitude matters for fertility, vitality, energy, mood, and sexual health, and whether the decline is real on average across the male population in the US and elsewhere. His question deliberately separates a statistical trend from clinical significance.

I think there is pretty convincing evidence that that is happening.

Eisenberg is careful to separate the observation from its cause, saying the reason is probably not certain. The evidence comes from cohort studies that recruited men in the 1980s, 1990s, and 2000s and, matching age for age, found lower testosterone in later-recruited men, plus NHANES, a longitudinal study run by the CDC, showing decline over decades. He offers competing explanations without settling on one: chemical exposure in adult, adolescent, or in utero life, and obesity. For obesity he gives two mechanisms. Testosterone is aromatized in peripheral fatty tissue, where aromatase converts it to estrogen, necessarily lowering circulating testosterone; and larger thighs insulate the testes, and the resulting heat effects can lower the efficiency of production a little. Huberman and Eisenberg jointly confirm that the testicular mechanism is specifically about heat effects.

Huberman raises the cell-phone question from within what he calls biohacky circles, a label he dislikes because it implies a shortcut or repurposing something for an unintended use. He offers a mechanistic intuition: a smartphone in the pocket could generate heat or radiation that impairs testicular function and therefore sperm quality and/or testosterone. He also cites a meta-analysis of uncertain quality suggesting heat-related or non-heat-related effects, and is precise about the exposure, stipulating that the phone is on and carried in the pocket, while noting the claim is common in those circles.

Eisenberg's answer is a study in evidentiary limits. He first corrects the framing: the concern is harm, not help, to testosterone, and he clarifies that sperm production is much more sensitive to heat than testosterone production. Early observational studies found lower semen quality in men who used cell phones more, but he notes that men who do and do not use phones differ in huge ways, making the experiment hard to design. In vitro work placing a phone next to a sperm sample in a cup, including studies that normalized heat on a special stage to isolate radio-frequency exposure, does not show a clinically meaningful change; some studies suggest DNA fragmentation may go up a little with close proximity. His clinical stance is that the data are not convincing, but that patients who want to do whatever they can to improve their chances can be aware of it, and that the biggest heat minimization is putting a laptop on a desk rather than in the lap.

Huberman introduces an anomalous observation from a behavioral endocrinology textbook by Randy Nelson: a graph of testosterone versus age showing average levels much higher in the late teens, early 20s, and 30s with a progressive decline, yet with individual scatter-plot outliers in their 50s, 60s, 70s, 80s, and even 90s whose levels are on par with men in their 30s. He reasons that since these values are already ceilinged around 900 nanograms per deciliter toward the high-end normal at age 90, it is hard to imagine the same men once walked around with 2,000 nanograms per deciliter, and asks whether Eisenberg sees such men over 40 with very high total and presumably free testosterone clinically.

Eisenberg confirms great variation and gives the population rule he uses with patients: testosterone usually peaks in the early 20s and tends to go down probably 1 percent a year forever. He reports screening testosterone in men presenting with low energy, low libido, and sexual dysfunction, and has seen 80-year-olds with the highest testosterone level he will see for six months. He explicitly declines to explain this, saying the reason is not certain and offering only tentative possibilities: a bell-shaped curve, differences in androgen receptor sensitivity, or making it more efficiently. A clinically important nuance is that men with very high levels may have some of the same dysfunction as men with low levels, so a high number does not by itself resolve symptoms, and there may be other issues going on.

Huberman reframes his question around prediction. Since a clinician can visually judge whether a patient looks obese, and since obesity was already named as a risk factor that lowers testosterone via aromatization to estrogen, he asks whether a non-obese, healthier-looking man is more likely to have normal testosterone and whether an obese man should be expected to be subnormal, or whether obese patients sometimes present with high testosterone. He is explicit that the goal is not confusion but deciding what is actually worth avoiding to preserve fertility and vitality, and asks how tight the obesity-testosterone correlation really is, short of a one-for-one relationship.

you cannot predict

Eisenberg's take-home is that prediction from appearance fails and that more information is always better. He describes patients who look totally normal, exercise five to seven days a week, and still have very low testosterone, sometimes having lived their whole lives without knowing what normal is until treatment makes them feel better. He then widens the frame: lower testosterone levels are associated with higher risk of heart disease, diabetes, and mortality, with the same studies existing for semen quality, so both act as health barometers. Returning to the decline debate, he offers a quantitative limitation: the purported decline in semen quality is about 50 percent, but overlaying the known association between obesity and semen quality, tracked against exactly how much fatter the population is now, explains only about a 10 percent decline, leaving something more that obesity alone cannot account for.

testosterone, semen quality, they've been shown to even be barometers of health

Asked what men should do and avoid, with Huberman carefully disclaiming the word optimizing because optimal is a day-to-day thing, Eisenberg starts with semen quality and names heat as the big modifiable risk factor: hot tubs, saunas, and, with light data, seat warmers. The physiological rationale is that the testicles sit outside the body because they need to be a little cooler, so any external heat source applied to the scrotum can certainly be a problem.

Huberman tests a personal workaround, noting he has recommended and used a cold pack on the groin during sauna use, on the reasoning that heat is bad for sperm and not quite as bad for testosterone, and asking whether overheating the testicle is generally bad for male endocrine function. Eisenberg agrees that spermatogenesis is a lot more sensitive, and that thwarting external heat with a cooling pack makes sense, citing studies that cooled the scrotum and compared semen quality before and after with some data that may help; but he qualifies the answer by how long one spends in the sauna and how cold the pack remains. The exchange then gets concrete about an ice pack used for 20 to 45 minutes and whether it is still cold afterwards.

Huberman describes commercially available cold packs worn in the shorts, which he says he uses at a Russian banya, with a thin insulating layer so the very cold surface is not in direct contact with scrotal skin and will not stick or damage skin on removal; he is careful to disclose no relationship to any of these companies. Eisenberg responds with a safety caveat rather than endorsing the practice unreservedly, and adds that in theory such cooling should be adequate to decrease the risk of that particular heat effect, while continuing to stress how linked general health and adequate sperm production are.

Frostbite to the scrotum is not theoretical.

Eisenberg repeatedly returns to general health as a determinant of sperm production. He cites studies showing that as comorbid conditions such as obesity, hypertension, and hyperlipidemia stack up, testicular function declines, with lower testosterone and lower sperm quality. He notes that fertility is often one of the first touch points men in their 20s, 30s, or 40s have with healthcare, since men generally see a doctor for pain or a problem, so some of these relationships have not yet been established in a primary-care setting. He then flags testosterone as a fairly common problem in fertility clinics and points out that exogenous testosterone has actually been tested as a contraceptive, with some other agents, and can be fairly effective, urging that men starting it do so for the right reasons and safely.

maybe about one in 20 infertile men are that way because of testosterone